Inmode Ltd (INMD) Stock Price, Quote & News

Company Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well a...

Industry: Medical Devices

Sector: Healthcare

Phone: 972 4 909 6313

Website: www.inmodemd.com

Address:

Tavor Building, Sha’ar Yokneam PO Box 533, Yokne'am, Israel

roblake29 Feb. 18 at 9:43 PM

$INMD My updated analysis. Despite my persistent reservations with management, I continue to be bullish. Call it a contrarian bet. Read here: https://seekingalpha.com/article/4871681-inmode-some-green-shoots-appearing-but-the-market-hasnt-noticed

0 · Reply

findingthestock Feb. 18 at 7:42 PM

$INMD Stock will crash with regional conflict Moshe will then sell for even less than $15 if stock is trading below $10

0 · Reply

_StockFox_ Feb. 18 at 3:39 PM

$INMD took some more..good luck fox friends..see you at the TOP $SPY $QQQ

0 · Reply

redbugs Feb. 18 at 1:18 PM

$INMD can someone please catch me up on where we are merger wise. Thanks.

0 · Reply

findingthestock Feb. 17 at 2:06 PM

$INMD

0 · Reply

findingthestock Feb. 14 at 3:23 AM

$INMD WAS THIS MOSHE PLAN ALL ALONG SOLD SHAres when price was near all time highs Now looking to take company and buy for cheap with his Israeli fund friends

0 · Reply

romroc25 Feb. 12 at 3:42 PM

$INMD of these guys had a billion in cash would they sit on it? Probably.

1 · Reply

findingthestock Feb. 12 at 10:37 AM

$INMD Drive share price into the ground, take private. Moshe is wanting this

0 · Reply

findingthestock Feb. 11 at 6:46 PM

$INMD Moshe wants to sell for $15

0 · Reply

findingthestock Feb. 11 at 2:38 PM

$INMD Moshe sold a lot and now looking to sell cheap and be taken care of with good compensation from Meir An investor group led by Meir Shamir, the controlling shareholder of Mivtach Shamir Holdings, and InMode CEO Moshe Mizrahy has submitted a bid.

0 · Reply

InMode: Some Green Shoots Appearing, But The Market Hasn't Noticed

Feb 10, 2026, 12:54 PM EST - 8 days ago

InMode Ltd. (INMD) Q4 2025 Earnings Call Transcript

Feb 10, 2026, 7:00 AM EST - 8 days ago

InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million

Feb 3, 2026, 8:00 AM EST - 15 days ago

InMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

Feb 2, 2026, 7:00 AM EST - 16 days ago

InMode Responds to Transaction Rumors

Jan 29, 2026, 12:44 PM EST - 20 days ago

Steel Partners Targets InMode, Citing Stock Underperformance

Jan 28, 2026, 5:30 PM EST - 20 days ago

Steel Partners Holdings L.P. Announces It Has Presented $18.00 Per Share Offer for 51% of InMode Ltd.

Jan 8, 2026, 7:00 AM EST - 5 weeks ago

InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8M

Dec 11, 2025, 6:26 PM EST - 2 months ago

InMode's Shares Are Too Cheap To Ignore: The Bottom May Be In

Nov 5, 2025, 12:51 PM EST - 3 months ago

InMode Ltd. (INMD) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 7:00 AM EST - 3 months ago

InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins

Nov 3, 2025, 8:05 AM EST - 3 months ago

InMode Appoints Michael Dennison as President of North America

Oct 30, 2025, 8:30 AM EDT - 3 months ago

InMode to Participate in Upcoming Investor Conferences

Oct 27, 2025, 2:07 PM EDT - 4 months ago

InMode: Discounted Valuation & Strong Fundamentals Make It A Buy

Oct 9, 2025, 7:00 AM EDT - 4 months ago

InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M

Sep 9, 2025, 8:15 AM EDT - 5 months ago

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Return Capital to the Shareholders

Sep 2, 2025, 8:30 AM EDT - 6 months ago

InMode to Present at Baird 2025 Global Healthcare Conference

Jul 30, 2025, 3:22 PM EDT - 7 months ago

InMode Ltd. (INMD) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 7:00 AM EDT - 7 months ago

InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins

Jul 12, 2025, 8:08 AM EDT - 7 months ago

InMode: Margin Pressure, But Optionality Makes It Worth A Look

Jul 10, 2025, 7:00 AM EDT - 7 months ago

InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M

May 28, 2025, 8:30 AM EDT - 9 months ago

InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025

May 9, 2025, 8:22 AM EDT - 10 months ago

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program

May 7, 2025, 8:30 AM EDT - 10 months ago

InMode to Present at Upcoming Investor Conferences and Events

May 6, 2025, 8:03 AM EDT - 10 months ago

InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges

Apr 29, 2025, 7:00 AM EDT - 10 months ago

InMode Q1 Earnings: Short-Term Catalysts Have Vanished (Rating Downgrade)

Apr 29, 2025, 1:52 AM EDT - 10 months ago

InMode: Equity Value Hinges On Cash, Not Future Prospects (Rating Downgrade)

Apr 28, 2025, 1:41 PM EDT - 10 months ago

Eyes On Park Introduces Revolutionary Envision by InMode System for Advanced Dry Eye Treatment in New York City

Apr 28, 2025, 11:53 AM EDT - 10 months ago

InMode Ltd. (INMD) Q1 2025 Earnings Call Transcript

Apr 28, 2025, 7:00 AM EDT - 10 months ago

InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease

Apr 3, 2025, 4:26 AM EDT - 11 months ago

InMode: Strategic Capital Allocation Unlocks Shareholder Value (Rating Upgrade)

Mar 26, 2025, 8:30 AM EDT - 11 months ago

InMode to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 6, 2025, 7:30 AM EST - 1 year ago

InMode Responds to Doma Perpetual's Letters

Mar 3, 2025, 8:30 AM EST - 1 year ago

InMode to Present at Upcoming Investor Conferences

Feb 10, 2025, 1:14 AM EST - 1 year ago

InMode: Plastic Surgery Boom, Cash Flow, And Cheap

Feb 6, 2025, 9:08 AM EST - 1 year ago

InMode Ltd. (INMD) Q4 2024 Earnings Call Transcript

Feb 4, 2025, 7:00 AM EST - 1 year ago

InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program

Feb 3, 2025, 8:30 AM EST - 1 year ago

InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

Jan 28, 2025, 9:32 AM EST - 1 year ago

InMode: A Clear Bargain With Unique Risks

Jan 16, 2025, 7:00 AM EST - 1 year ago

InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced

Jan 15, 2025, 8:05 AM EST - 1 year ago

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback

Jan 10, 2025, 6:07 AM EST - 1 year ago

InMode: Clearly, I Was Too Optimistic (Rating Downgrade)

Jan 8, 2025, 7:00 AM EST - 1 year ago

InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M

Dec 12, 2024, 1:17 AM EST - 1 year ago

InMode: Product Origination And Undervaluation Make The Stock A Buy

Nov 5, 2024, 9:43 AM EST - 1 year ago

InMode: $25/Share Is Closer Than You Think

Oct 31, 2024, 12:16 PM EDT - 1 year ago

InMode: A Deep Dive After Q3 Earnings

Oct 30, 2024, 11:33 AM EDT - 1 year ago

InMode Ltd. (INMD) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 7:00 AM EDT - 1 year ago

InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024)

Oct 24, 2024, 7:03 AM EDT - 1 year ago

InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories

Oct 10, 2024, 7:00 AM EDT - 1 year ago

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024

roblake29 Feb. 18 at 9:43 PM

0 · Reply

findingthestock Feb. 18 at 7:42 PM

$INMD Stock will crash with regional conflict Moshe will then sell for even less than $15 if stock is trading below $10

0 · Reply

_StockFox_ Feb. 18 at 3:39 PM

$INMD took some more..good luck fox friends..see you at the TOP $SPY $QQQ

0 · Reply

redbugs Feb. 18 at 1:18 PM

$INMD can someone please catch me up on where we are merger wise. Thanks.

0 · Reply

findingthestock Feb. 17 at 2:06 PM

$INMD

0 · Reply

findingthestock Feb. 14 at 3:23 AM

$INMD WAS THIS MOSHE PLAN ALL ALONG SOLD SHAres when price was near all time highs Now looking to take company and buy for cheap with his Israeli fund friends

0 · Reply

romroc25 Feb. 12 at 3:42 PM

$INMD of these guys had a billion in cash would they sit on it? Probably.

1 · Reply

findingthestock Feb. 12 at 10:37 AM

$INMD Drive share price into the ground, take private. Moshe is wanting this

0 · Reply

findingthestock Feb. 11 at 6:46 PM

$INMD Moshe wants to sell for $15

0 · Reply

findingthestock Feb. 11 at 2:38 PM

0 · Reply

gzak55 Feb. 11 at 2:29 PM

$INMD another bidder published today. Report: South Korean Fund Seeks Control of InMode (INMD) According to foreign media reports, South Korean private equity firm Centroid is looking to acquire a controlling stake in medical aesthetics company InMode (INMD). The report cites anonymous investment banking sources. Centroid is expected to compete with Steel Partners, which has already submitted an offer to purchase 51% of InMode at $18 per share. The reported valuation for the potential transaction is approximately $1.1 billion.

0 · Reply

findingthestock Feb. 11 at 2:13 PM

$INMD we need more bidders and shareholders like DOMA to make noise and move the stock up

0 · Reply

LunkerInvesting Feb. 10 at 8:51 PM

$INMD sorry folks but hope is never a plan. This is a classic if you smell smoke there is a fire situation. CEO took shareholders hostage and I took the deal to quick but 16.50 was a chance to sell and a gift. Sorry folks

0 · Reply

Z3mcoupe999 Feb. 10 at 8:37 PM

$INMD one of the worst communicating CEOs I have ever heard definitely not someone to have any faith in

0 · Reply

findingthestock Feb. 10 at 4:59 PM

$INMD

0 · Reply

findingthestock Feb. 10 at 4:56 PM

$INMD shareholders should not accept Moshe low value deal

0 · Reply

findingthestock Feb. 10 at 3:53 PM

$INMD TRANSCRIPT CALL https://in.investing.com/news/transcripts/earnings-call-transcript-inmode-q4-2025-posts-earnings-beat-stock-dips-93CH-5232244

0 · Reply

findingthestock Feb. 10 at 2:55 PM

$INMD there is only one offer that is from Israeli fund that Moshe has stake in and will sell for $15 a share The Korean company not sure how serious their offer is no mention of them and Steele didn’t go proper router in tendering an offer Moshe will screw shareholders!!

1 · Reply

findingthestock Feb. 10 at 2:20 PM

$INMD Fustrated investors losing a lot

0 · Reply

findingthestock Feb. 10 at 2:19 PM

$INMD this call is horrible Moshe tanking the stock and won’t sell to Steele or any other bidders that may come

1 · Reply

findingthestock Feb. 10 at 1:54 PM

$INMD MOSHE just said Steel company offer is bogus and they haven’t heard back from them

1 · Reply

findingthestock Feb. 10 at 12:59 PM

$INMD Moshe will drive stock price down He will only sell to Israeli fund for cheap and take company private They will not sell to Steel and cite some bogus reason Looking up Moshe and previous companies he left in a mess this how he operates

1 · Reply

Market Cap	906.03M
Revenue (ttm)	394.82M
Net Income (ttm)	181.28M
EPS (ttm)	N/A
PE Ratio	9.93
Forward PE	N/A
Profit Margin	45.91%
Debt to Equity Ratio	0.00

Volume	579,249
Avg Vol	954,724
Day's Range	N/A - N/A
Shares Out	63.36M
Stochastic %K	17%
Beta	2.19
Analysts	Sell
Price Target	$16.80